Copyright © 2013 Elsevier Inc. All rights reserved.

Slides:



Advertisements
Similar presentations
Chapter 42 Chapter 42 Bone Acquisition in Adolescence Copyright © 2013 Elsevier Inc. All rights reserved.
Advertisements

Chapter 68 Chapter 68 Fracture Risk Assessment: The Development and Application of FRAX ® Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 31 Chapter 31 Clinical and Epidemiological Studies: Skeletal Changes across Menopause Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 85 Chapter 85 Parathyroid Hormone Treatment for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 77 Chapter 77 Estrogen and Estrogen Analogs for Prevention and Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Physical Activity and Bone Health during Childhood and Adolescence: Critical Periods for the Prevention of Osteoporosis Suggested Links (click below)
Chapter 41 Chapter 41 Bone Mineral Acquisition in Utero and During Infancy and Childhood Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 66 Chapter 66 Clinical Use of Bone Densitometry Copyright © 2013 Elsevier Inc. All rights reserved.
WHO Osteoporosis Definition (1996)
OSC Recommendations for Bone Mineral Density Reporting Slides prepared by Kerry Siminoski, MD, FRCPC William Leslie, M.Sc., MD,
Bone Mineral Density Testing March 29, Introduction Osteoporosis is a systemic skeletal disorder characterized by decreased bone mass and deterioration.
Treatment. Bisphosphonates Promotes bone formation and decreases bone resorption Mechanism of Action First line treatment for osteoporosis in both men.
Chapter 9 Skeletal health. Chapter overview Introduction Biology of bone Osteoporosis: definition, prevalence and consequences Physical activity and bone.
OSTEOPOROSIS Prof. Dr. Ülkü Akarırmak. Metabolic Bone Diseases Osteosclerosis Osteolysis Osteoporosis is the most common metabolic bone disease.
Glucocorticoid-Induced Osteoporosis (GIO) Nguyen Thy Khue, MD, PhD Department of Endocrinology, HoChiMinh City University of Medicine and Pharmacy.
Chapter 83 Chapter 83 Denosumab for the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 84 Chapter 84 Strontium Ranelate in the Prevention of Osteoporotic Fractures Copyright © 2013 Elsevier Inc. All rights reserved.
Exercise and the Elderly. Physiological Changes With Aging Aging or decrease in activity? Quality years.
Chapter 28 Chapter 28 Nutrition and Risk for Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Extended Treatment Effects with Zoledronic Acid Based on Poster 1070 “The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment in Osteoporosis: a Randomized.
Hip Fractures Based on a Plenary Symposium “The Hip Fracture Epidemic” Chairs: Dennis Black, Bess Dawson-Hughes Speakers: Mary Bouxsein, Tamara Harris,
Chapter 72 Chapter 72 Calcium in the Treatment of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 25 Chapter 25 Genetic Determinants of Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Chapter 54 Chapter 54 HIV and Osteoporosis Copyright © 2013 Elsevier Inc. All rights reserved.
Osteoporosis Armed Forces Academy of Medical Sciences.
Osteoporosis Dr Ramin Rafiei Alzahra Hospital Rheumatology Department.
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
Prevention and Treatment of Osteoporosis
Improving Evaluation and Treatment for Osteoporosis Following Distal Radial Fractures by Tamara D. Rozental, Eric C. Makhni, Charles S. Day, and Mary L.
Weekly Alendronate Safe and Effective at Increasing Bone Mineral Density in HIV-Infected Persons on Antiretroviral Therapy Slideset on: McComsey GA, Kendall.
Chapter 41: Role of Sex Steroids in the Pathogenesis of Osteoporosis Matthew T. Drake and Sundeep Khosla.
Chapter 47 Assessing Fracture Risk: Who Should Be Screened? © American Society for Bone and Mineral Research Contributed by John Schousboe, Brent Taylor,
Moji Saberin-Williams, M.D. Paoli Hospital Obstetrician/Gynecologist
R1 김형오 / Prof. 김덕윤 1.  Osteoporosis  Asian region is considered to be on the verge of an emerging osteoporosis epidemic  50% of the world’s osteoporotic.
Osteopenia and Osteoporosis
Chapter 29: DXA in Adults and Children Judith Adams and Nick Bishop.
Date of download: 9/18/2016 From: Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial.
Therapeutic Implications
Copyright © 2005 American Medical Association. All rights reserved.
Volume 48, Issue 4, Pages (April 2011)
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis  Peyman Hadji  Critical Reviews in Oncology.
This patient has a total hip bone mineral density (BMD) of 0
Copyright © 2011 American Medical Association. All rights reserved.
Chapter 38: Epidemiology of Osteoporotic Fractures
Algorithm of the approach to the diagnosis and treatment of children with fractures due to osteoporosis. BMD, bone mineral density; GC, glucocorticoids;
Copyright © 2011 American Medical Association. All rights reserved.
FRAX & ITS ASSOCIATIONS IN RHEUMATOID ARTHRITIS
Figure 1. Serum B-ALP levels in normal male (•) and female (○) children as a function of age. Serum B-ALP levels were increased during infancy and puberty.
Post Menopausal Osteoporosis
Osteoporosis Diagnosis 9/21/2018 OSTEOPOROSIS.
Osteoporosis in Individuals with Spinal Cord Injury
Case for androgens Giorgio Arnaldi Clinica di Endocrinologia
Shannon D. Sullivan, M. D. , Philip M. Sarrel, M. D. , Lawrence M
The Roles of Bone Mineral Density, Bone Turnover, and Other Properties in Reducing Fracture Risk During Antiresorptive Therapy  Solomon Epstein, MD  Mayo.
Ross operation: 16-year experience
Polymorphisms in the Low-Density Lipoprotein Receptor–Related Protein 5 (LRP5) Gene Are Associated with Variation in Vertebral Bone Mass, Vertebral Bone.
Volume 66, Issue 5, Pages (November 2004)
Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis 
Yi Zuo, Aerie Lin, Paul Chang, Wen-Biao Gan  Neuron 
Chapter 45 Osteoporosis in AdultsPhoto Album
Cancer Treatment-Induced Bone Loss (CTIBL) in Prostate Cancer: Pathophysiology, Preclinical Findings, and Treatment with Zoledronic Acid  Theresa A. Guise,
Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome  Janet Hegarty, M. Zulf Mughal, Judith.
Reporting the Results of DXA Scan
Interpretation The World Health Organization (WHO) Osteoporosis Guidelines (T Score vs Z score) A Z-score less than –2 indicates the diagnosis is below.
H.J. Heller, J.E. Zerwekh, F.A. Gottschalk, C.Y.C. Pak 
Enrollment and Outcomes
Chapter 44 Osteoporosis: The Early Years
Volume 79, Issue 4, Pages (February 2011)
DEXA Techniques DEXA is a quick method that is:
Figure 1. Relative risks of vertebral, hip, and nonvertebral fractures (and 95% CIs) in response to the treatments for ... Figure 1. Relative risks of.
Presentation transcript:

Copyright © 2013 Elsevier Inc. All rights reserved. Chapter 32 Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.1 Average annual fracture incidence rate in males and females per 10,000 population, by age group. Source: Donaldson et al. (1990) [572]. Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.2 Age-specific and sex-specific incidence of radio­graphic vertebral, hip, and distal forearm fractures in Europe. Source: Sambrook and Cooper (2006), with permission [573]. 3 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.3 Annual age-standardized rates of hip fracture by sex per 100,000 person-years in Canada. There appears to be a gradual decline in fracture rates that may have become more accentuated since 1995. Source: Leslie et al. (2009), with permission [31]. 4 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.4 Annual numbers of hip fractures, unadjusted hip fracture rates, and age-standardized hip fracture rates per 100,000 person-years in Canada. Although the fracture rate had declined, the numbers of hip fractures has increased because of the expansion in the elderly population. Source: Leslie et al. (2009), with permission [31]. 5 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.5 Observed and expected race- and sex-specific survival following fracture of the hip, all ages combined. Source: Jacobson et al. (1992), with permission [574]. 6 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.6 Os calcis bone mineral content of men by 5-year age groups and grade of osteoporosis (n = 821). Each point and bar represents the mean and standard error of the mean (SE), respectively. Grade 0, normal (no radiographic evidence of vertebral demineralization or fracture). Grades 1–3, progressively severe vertebral demineralization and fracture. Source: Ross et al. (1988), with permission [89]. 7 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.7 Incidence of new vertebral fractures (1981–1994) among men and women in the Hawaii Osteoporosis Study (HOS), by quartiles of baseline calcaneus bone mineral density (BMD). Source: Ross et al. (1999), with permission [91]. 8 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.8 Axial cross-sectional area, transverse diameter, anteroposterior diameter, and vertebral body volume of the first (L1), second (L2), and third (L3) lumbar vertebral bodies in 12 pairs of men and women matched for age, vertebral body height, and bone density. Values are mean ± 1 standard deviation (SD) *p < 0.001. Values in men are shown by the open bars; values in women are shown by shaded bars. Source: Gilsanz et al. (1994), with permission [575]. 9 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.9 Bone mass gain at the lumbar spine during ado­lescence. The yearly increase in lumbar spine bone mineral density (BMD) (A) and bone mineral content (BMC) (B) is depicted in males and females (mean ± standard error of the mean (SE)). Source: Theintz et al. (1992), with permission [576]. 10 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.10 Mean yearly rate of change in bone mineral density (BMD) and 95% confidence interval according to age group and sex, the Rotterdam Study, The Netherlands, 1990-1995, p values are for linear trends. Source: Burger et al. (1998), with permission [141]. 11 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.11 Age-related changes in the calculated failure moment of male and female human femoral shafts in bending. The slope of the female data is significantly different from 0. Source: Martin (1993), with permission [138]. 12 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.12 Changes in trabecular number (solid lines) and trabecular width (dashed lines) with age in the iliac crest of men and women. Source: Aaron et al. (1987), with permission [193]. 13 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.13 The ratio of urinary pyridinoline (PYR) to urinary creatinine excretion (mean ± standard error of the mean (SE)) in 440 adults expressed as a percentage of values in young adults. Source: Kanis and Adami (1994), with permission [535]. 14 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.14 The associations between serum total and free estradiol levels and fracture risk in older Swedish men. Source: Mellstrom et al. (2008), with permission [297]. 15 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.15 The relationships between bone mineral density (BMD) of the lumbar spine, femoral neck, and femoral shaft and pubertal stages in male and female subject (* p < 0.05). SEM: standard error of the mean. Source: Bonjour et al. (1991), with permission [151]. 16 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.16 Changes in Va (dietary calcium absorption), Vbal (net calcium retention), and vo+ (rate of bone accretion) in prepubertal children treated with testosterone (n = 6). Solid bars, before testosterone; hatched bars, after testosterone. *p < 0.05. Source: Mauras et al. (1999), with permission [344]. 17 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.17 Radial bone mineral density in 23 men with a history of delayed puberty and 21 normal men. Source: Finkelstein et al. (1992), with permission [355]. 18 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.18 The time course of osteoblastic cell proliferation evaluated by deoxyribonucleic acid (DNA) synthesis in bone samples from osteoporotic men with low (open circles) or normal (open triangles) bone formation as determined by the extent of double-labeled surface, compared to normal bone cells (solid squares) (mean ± standard error of the mean (SE)). cpm: counts per minute. Source: Marie et al. (1991), with permission [315]. 19 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.19 Nonvertebral fracture risk and the combined effects of bone mineral density (BMD) and clinical factors. Fracture risk increases substantially as bone density decreases and the number of clinical factors that are associated with fracture increases. Source: Lewis et al. (2007), with permission [72]. 20 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.20 General approach to the diagnosis and evaluation of osteoporosis in men. BMD: bone mineral density; SD: standard deviation; W/U: work-up. Source: Orwoll (1999), with permission [536]. 21 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.21 Lumbar spine (A) and femoral neck (B) bone mineral density (BMD) in male subjects with and without vertebral deformity. Four grades of vertebral deformity are illustrated (anterior vertebral/posterior vertebral height ration of < 0.85, or < 0.80, and anterior vertebral heights < 2 standard deviations (SD) or < 3 SD of a population mean. Source: Mann et al. (1992), with permission [51]. 22 Copyright © 2013 Elsevier Inc. All rights reserved.

Copyright © 2013 Elsevier Inc. All rights reserved. FIGURE 32.22 Rate of change in bone mineral density (BMD) of lumbar spine during control or testosterone treatment periods (each of 6 months’ duration) in men receiving glucocorticoid therapy. Data are given as the mean ± standard error or the mean (SEM). There was a significant difference between groups (p = 0.05). The asterisk indicates a significant difference from 0 (p = 0.005). Source: Reid et al. (1996), with permission [566]. 23 Copyright © 2013 Elsevier Inc. All rights reserved.